Individualized luteal phase support using additional oral dydrogesterone in artificially prepared frozen embryo transfer cycles: is it beneficial?
Reproductive BioMedicine Online · 2023
DOI: 10.1016/j.rbmo.2023.02.007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2023. Verfasst von Shari Mackens und 8 weiteren Autor:innen. Beteiligte Einrichtung: Brussels IVF, Universitair Ziekenhuis Brussel, Brussels, Belgium; Research group Reproduction and Immunology (REIM), Vrije Universiteit Brussel, Brus…. Hauptthemen laut MEDLINE: Dydrogesterone, Progesterone. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
RESEARCH QUESTION: Does additional supplementation with oral dydrogesterone improve reproductive outcomes in patients with low serum progesterone concentrations on the day of frozen embryo transfer (FET) after artificial (HRT) endometrial preparation? DESIGN: Retrospective, single-centre cohort study including 694 unique patients performing single blastocyst transfer in an HRT cycle. For luteal phase support, intravaginal micronized vaginal progesterone (MVP, 400 mg twice daily) was administered. Serum progesterone concentrations were assessed prior to FET and outco-mes were compared among patients with normal serum progesterone (≥8.8 ng/ml) continuing the routine protocol and patients with low serum progesterone (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Brussels IVF, Universitair Ziekenhuis Brussel, Brussels, Belgium; Research group Reproduction and Immunology (REIM), Vrije Universiteit Brussel, Brussels, Belgium. Electronic address: Shari.Mackens@uzbrussel.be.
- Brussels IVF, Universitair Ziekenhuis Brussel, Brussels, Belgium; Departamento de Ginecología y Obstetricia, Clínica Alemana, Facultad de Medicina, Universidad del Desarrollo, Santiago, Chile.
- Brussels IVF, Universitair Ziekenhuis Brussel, Brussels, Belgium; IVF Athens, Kolonaki, Athens, Greece; Embryolab IVF Unit, Thessaloniki, Greece.
- Brussels IVF, Universitair Ziekenhuis Brussel, Brussels, Belgium.
- Brussels IVF, Universitair Ziekenhuis Brussel, Brussels, Belgium; Department of Obstetrics, Gynecology, Perinatology and Reproductology, Institute of Professional Education, Sechenov University, Moscow, Russia.
- Brussels IVF, Universitair Ziekenhuis Brussel, Brussels, Belgium; Department of Obstetrics and Gynaecology, School of Medicine, University of Zagreb, Croatia.
Zitieren
APA
Mackens, S., Pais, F., Drakopoulos, P., Amghizar, S., Roelens, C., Van Landuyt, L., Tournaye, H., De Vos, M., & Blockeel, C. (2023). Individualized luteal phase support using additional oral dydrogesterone in artificially prepared frozen embryo transfer cycles: is it beneficial?. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2023.02.007
Vancouver
Mackens S, Pais F, Drakopoulos P, Amghizar S, Roelens C, Van Landuyt L, et al. Individualized luteal phase support using additional oral dydrogesterone in artificially prepared frozen embryo transfer cycles: is it beneficial?. Reproductive BioMedicine Online. 2023. doi:10.1016/j.rbmo.2023.02.007
BibTeX
@article{Mackens2023,
author = {Mackens, Shari and Pais, Francisca and Drakopoulos, Panagiotis and Amghizar, Samah and Roelens, Caroline and Van Landuyt, Lisbet and Tournaye, Herman and De Vos, Michel and Blockeel, Christophe},
title = {Individualized luteal phase support using additional oral dydrogesterone in artificially prepared frozen embryo transfer cycles: is it beneficial?},
journal = {Reproductive BioMedicine Online},
year = {2023},
doi = {10.1016/j.rbmo.2023.02.007}
}
EUVIMED